The Human Viral Challenge Model demonstrates the efficacy Enanta’s new N protein inhibitor.

The Human Viral Challenge Model demonstrates Highly Statistically Significant Reductions in Total Symptom Score, Mucus Weight and RSV Viral Load for Enanta’s new N protein inhibitor. http://ow.ly/hrWy30pFaJZ